Back to trial details

Intake questionnaire

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

Applying to University of Chicago · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Solid Tumor?
3. Are you able to travel to Chicago for study visits?